It’s long been said that you are what you eat. In other words, if you want to live your best life, you need to eat the best foods possible for maintaining good health – and this includes the fruits that you eat daily.

Bergamot (Citrus bergamia Risso) is a highly specific species of citrus cultivation, diffused mainly in the Reggio Calabria Province – Italy, in the most coastal part of the area due to the special characteristics of its Mediterranean microclimate. Bergamot is a citrus fruit that looks like an orange but has the brilliant yellow colouring of a lemon with a tart citrus taste, slightly reminiscent of a grapefruit. The juice has been used for decades by locals as a remedy for overall cardiovascular health thanks to its unique and powerful natural compounds that cannot be found in other citrus fruits.

In order to take advantage of all the benefits of bergamot fruit, Giellepi developed Kalita®, a standardized bergamot phytocomplex in water- dispersible powder form. Kalita®’s cardiometabolic- supporting power has been validated by a preclinical study in rats fed with a high fat/high sugar diet as well as by a double-blind, randomized, placebo controlled trial on overweight volunteers who meet criteria for metabolic syndrome.

Bergamot phytocomplex expressed as polysaccharides and pectines, total polyphenols and amino acid derivates


Recommended daily dosage:
350-700 mg

Tablets, capsules, powders, gummies


Kalita® is created through a proprietary clean water extraction technology process. Our patent pending technology preserves the delicate bioactive compounds that are usually removed in conventionally processed bergamot extracts. The result is a broad-spectrum bergamot extract that has been shown to contain a broad bioactive profile including a large amount of soluble fiber in the form of polysaccharides and pectins, amino acid derivates and key phenolic compounds naturally found in the whole fruit.

Kalita® provides the many benefits of bergamot extract in a low daily dose.


  • Overweight subject with poor cardiometabolic health outcomes
  • Subjects with unbalanced lipid profile
  • Anyone wanting to optimize insulin sensitivity
  • Subjects with less-than-optimal liver markers
  • Subjects who want to promote a balanced inflammatory response

Clinical evidence

Kalita® has been the subject of a 3-arm double-blind, randomized, placebo-controlled trial on a group of overweight subjects with features of metabolic syndrome. The effect of Kalita® low and high dosage on a large panel of parameters including lipid, glucose, liver and inflammation blood markers was monitored during the study.


1. Improvements in lipid blood markers (TG/HDL-C ratio)

2. Benefits on Insulin sensitivity (HOMA-IR)

3. Reduces Non-specific biomarker of inflammation (CRP)


Della Vedova et al. Molecules 2023; 28, 2964.
Fogacci et al. Arch Med Sci. 2023; 19(5):1228–1235.

Giellepi solutions

Our legacy of expertise and innovation drives us to create nutritional solutions to support healthy lifestyles.